X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (35045) 35045
Magazine Article (566) 566
Newsletter (350) 350
Newspaper Article (147) 147
Book Chapter (86) 86
Book / eBook (50) 50
Transcript (36) 36
Web Resource (26) 26
Conference Proceeding (18) 18
Book Review (14) 14
Dissertation (8) 8
Reference (8) 8
Publication (4) 4
Streaming Video (3) 3
Report (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28954) 28954
anticonvulsants - therapeutic use (26526) 26526
male (16228) 16228
female (15687) 15687
clinical neurology (12018) 12018
epilepsy (11497) 11497
epilepsy - drug therapy (10987) 10987
adult (10569) 10569
anticonvulsants (7497) 7497
anticonvulsants - adverse effects (7129) 7129
child (6985) 6985
adolescent (6944) 6944
seizures (6904) 6904
middle aged (6728) 6728
animals (6599) 6599
treatment outcome (5180) 5180
pharmacology & pharmacy (4772) 4772
neurosciences (4543) 4543
antiepileptic drugs (4456) 4456
neurology (4252) 4252
electroencephalography (4096) 4096
child, preschool (4094) 4094
seizures - drug therapy (4051) 4051
aged (4041) 4041
psychiatry (3864) 3864
anticonvulsants - pharmacology (3744) 3744
anticonvulsants - administration & dosage (3337) 3337
drug therapy, combination (3070) 3070
infant (2917) 2917
children (2888) 2888
carbamazepine (2860) 2860
dose-response relationship, drug (2781) 2781
rats (2762) 2762
valproic acid - therapeutic use (2660) 2660
drug therapy (2485) 2485
carbamazepine - therapeutic use (2457) 2457
retrospective studies (2401) 2401
mice (2393) 2393
analysis (2365) 2365
double-blind (2365) 2365
young adult (2265) 2265
pediatrics (2226) 2226
drugs (2100) 2100
pregnancy (2013) 2013
lamotrigine (1995) 1995
anticonvulsants - pharmacokinetics (1905) 1905
care and treatment (1889) 1889
risk factors (1883) 1883
follow-up studies (1788) 1788
time factors (1786) 1786
efficacy (1770) 1770
phenytoin (1758) 1758
drug interactions (1746) 1746
epilepsy - physiopathology (1728) 1728
epilepsies, partial - drug therapy (1697) 1697
epilepsy - diagnosis (1624) 1624
valproic acid (1603) 1603
phenytoin - therapeutic use (1601) 1601
status epilepticus (1589) 1589
disease models, animal (1586) 1586
anticonvulsant (1536) 1536
magnetic resonance imaging (1505) 1505
medicine, general & internal (1474) 1474
prognosis (1450) 1450
seizures - etiology (1423) 1423
therapy (1407) 1407
infant, newborn (1405) 1405
anticonvulsants - blood (1403) 1403
pharmacokinetics (1375) 1375
drug resistance (1365) 1365
topiramate (1365) 1365
medicine & public health (1341) 1341
brain (1310) 1310
status epilepticus - drug therapy (1309) 1309
seizures - chemically induced (1293) 1293
prospective studies (1287) 1287
health aspects (1273) 1273
triazines - therapeutic use (1265) 1265
levetiracetam (1250) 1250
piracetam - analogs & derivatives (1242) 1242
fructose - analogs & derivatives (1239) 1239
epilepsy - complications (1208) 1208
research (1203) 1203
epilepsy - epidemiology (1200) 1200
diagnosis, differential (1181) 1181
bipolar disorder - drug therapy (1165) 1165
behavioral sciences (1163) 1163
antidepressive agents - therapeutic use (1157) 1157
age factors (1141) 1141
valproate (1105) 1105
aged, 80 and over (1099) 1099
gabapentin (1089) 1089
double-blind method (1088) 1088
seizures - prevention & control (1088) 1088
phenobarbital - therapeutic use (1072) 1072
epilepsy - etiology (1070) 1070
antipsychotic agents - therapeutic use (1068) 1068
seizures - physiopathology (1065) 1065
fructose - therapeutic use (1045) 1045
surgery (1038) 1038
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (32154) 32154
German (1001) 1001
Spanish (788) 788
French (777) 777
Russian (500) 500
Japanese (347) 347
Italian (180) 180
Polish (171) 171
Chinese (122) 122
Portuguese (89) 89
Dutch (81) 81
Danish (80) 80
Hungarian (56) 56
Norwegian (54) 54
Czech (40) 40
Hebrew (39) 39
Croatian (33) 33
Finnish (33) 33
Swedish (31) 31
Serbian (21) 21
Romanian (15) 15
Ukrainian (15) 15
Slovak (7) 7
Bulgarian (6) 6
Turkish (4) 4
Bosnian (3) 3
Korean (3) 3
Lithuanian (3) 3
Arabic (2) 2
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Psychiatry and clinical neurosciences, ISSN 1323-1316, 2015, Volume 69, Issue 6, pp. 321 - 334
Tardive dyskinesia is a serious, disabling and potentially permanent, neurological hyperkinetic movement disorder that occurs after months or years of taking... 
first‐generation agents | schizophrenia | management | second‐generation agents | tardive dyskinesia | second-generation agents | first-generation agents | VITAMIN-E TREATMENT | NEUROTROPHIC FACTOR LEVELS | SCHIZOPHRENIC-PATIENTS | PSYCHIATRY | GINKGO-BILOBA | CHAIN AMINO-ACIDS | NEUROSCIENCES | ATYPICAL ANTIPSYCHOTICS | CLINICAL NEUROLOGY | HYPERKINETIC MOVEMENT-DISORDERS | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | ESSENTIAL FATTY-ACIDS | Stilbenes - therapeutic use | Antipsychotic Agents - adverse effects | Humans | Propranolol - therapeutic use | Leucine - therapeutic use | Dopamine Agents - therapeutic use | Amantadine - therapeutic use | Piracetam - therapeutic use | Pyridoxine - therapeutic use | Clonazepam - therapeutic use | Drugs, Chinese Herbal - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Adrenergic Uptake Inhibitors - therapeutic use | Anticonvulsants - therapeutic use | Nootropic Agents - therapeutic use | Isoleucine - therapeutic use | Vitamins - therapeutic use | Ginkgo biloba | alpha-Tocopherol - therapeutic use | Antioxidants - therapeutic use | Movement Disorders - etiology | Piracetam - analogs & derivatives | Melatonin - therapeutic use | Fatty Acids, Omega-3 - therapeutic use | Valine - therapeutic use | Isoxazoles - therapeutic use | Plant Extracts - therapeutic use | Movement Disorders - drug therapy | Tetrabenazine - therapeutic use | Schizophrenia | Movement disorders | Tardive dyskinesia | Medical research
Journal Article
Journal Article
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2018, Issue 7, p. CD006380
Background This is an updated version of the original Cochrane review published in Issue 12, 2011. Phantom limb pain (PLP) is pain that arises in the missing... 
Analgesics, Opioid | Neurotoxins | 2019 3.7 Other chronic pain | Antidepressive Agents | Pain & anaesthesia | Management | Anesthetics | 2019 3. Chronic pain | Phantom Limb | Randomized Controlled Trials as Topic | Receptors, N‐Methyl‐D‐Aspartate | Anticonvulsants | Chronic non‐cancer pain | Orthopaedics & trauma | Chronic non‐cancer pain management | Botulinum Toxins, Type A | Calcitonin | Child health | Amputation | Pharmacological therapies | Medicine General & Introductory Medical Sciences | LONG-TERM | Calcitonin [therapeutic use] | Anticonvulsants [therapeutic use] | Antidepressive Agents [therapeutic use] | Humans | Analgesics, Opioid [therapeutic use] | TOXIN TYPE-A | RANDOMIZED DOUBLE-BLIND | STUMP PAIN | Anesthetics [therapeutic use] | BOTULINUM-TOXIN | NEUROPATHIC PAIN | MEDICINE, GENERAL & INTERNAL | POSTAMPUTATION PHANTOM | Receptors, N-Methyl-D-Aspartate [antagonists & inhibitors] | RECEPTOR ANTAGONIST MEMANTINE | QUALITY-OF-LIFE | Phantom Limb [drug therapy] | CHRONIC NONCANCER PAIN | Antidepressive Agents - therapeutic use | Botulinum Toxins, Type A - therapeutic use | Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors | Anesthetics - therapeutic use | Phantom Limb - drug therapy | Anticonvulsants - therapeutic use | Analgesics, Opioid - therapeutic use | Calcitonin - therapeutic use | Neurotoxins - therapeutic use
Journal Article
Lancet neurology, ISSN 1474-4422, 2011, Volume 10, Issue 7, pp. 609 - 617
Journal Article
Clinics in Perinatology, ISSN 0095-5108, 2019, Volume 46, Issue 2, pp. 311 - 311
Journal Article
Journal of Emergency Medicine, ISSN 0736-4679, 2017, Volume 53, Issue 1, pp. 38 - 48
Abstract Background Intranasal (IN) medication delivery is a viable alternative to other routes of administration, including intravenous (IV) and intramuscular... 
Emergency | nasal | intranasal | medication | prehospital | emergency department | RECTAL DIAZEPAM | STATUS EPILEPTICUS | LACERATION REPAIR | RANDOMIZED CONTROLLED-TRIAL | PROCEDURAL SEDATION | POSTOPERATIVE PAIN MANAGEMENT | ACUTE SEIZURES | EMERGENCY MEDICINE | DOUBLE-BLIND | OPIOID OVERDOSE | INTRAVENOUS LORAZEPAM | Fentanyl - administration & dosage | Anesthetics, Dissociative - therapeutic use | Emergency Service, Hospital - trends | Narcotic Antagonists - administration & dosage | Fentanyl - therapeutic use | Humans | Hypnotics and Sedatives - administration & dosage | Haloperidol - administration & dosage | Midazolam - administration & dosage | Anticonvulsants - administration & dosage | Narcotics - therapeutic use | Antidotes - administration & dosage | Hypnotics and Sedatives - therapeutic use | Ketamine - administration & dosage | Lorazepam - therapeutic use | Administration, Intranasal - methods | Antipsychotic Agents - therapeutic use | Emergency Service, Hospital - organization & administration | Flumazenil - administration & dosage | Midazolam - therapeutic use | Ketamine - therapeutic use | Dexmedetomidine - administration & dosage | Dexmedetomidine - therapeutic use | Anesthetics, Dissociative - administration & dosage | Anticonvulsants - therapeutic use | Haloperidol - therapeutic use | Naloxone - therapeutic use | Lorazepam - administration & dosage | Antipsychotic Agents - administration & dosage | Flumazenil - therapeutic use | Hydromorphone - administration & dosage | Narcotics - administration & dosage | Narcotic Antagonists - therapeutic use | Hydromorphone - therapeutic use | Naloxone - administration & dosage | Antidotes - therapeutic use | Drugs | Usage | Emergency service | Hospitals | Emergency medicine
Journal Article
Journal Article
Book Review
American Journal of Medicine, The, ISSN 0002-9343, 2014, Volume 127, Issue 10, pp. 931 - 932
Internal Medicine | MEDICINE, GENERAL & INTERNAL | STEVENS-JOHNSON-SYNDROME | Acetaminophen - adverse effects | Dacarbazine - adverse effects | Methylprednisolone - therapeutic use | Humans | Middle Aged | Dexamethasone - adverse effects | Male | Antineoplastic Agents - therapeutic use | Wound Healing | Anticonvulsants - adverse effects | Piracetam - therapeutic use | Stevens-Johnson Syndrome - therapy | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Antiemetics - adverse effects | Oxycodone - therapeutic use | Stevens-Johnson Syndrome - etiology | Anticonvulsants - therapeutic use | gamma-Globulins - therapeutic use | Analgesics, Opioid - therapeutic use | Stevens-Johnson Syndrome - diagnosis | Dexamethasone - therapeutic use | Glioblastoma - pathology | Piracetam - analogs & derivatives | Glioblastoma - complications | Glioblastoma - drug therapy | gamma-Globulins - administration & dosage | Dacarbazine - therapeutic use | Piracetam - adverse effects | Erythema - chemically induced | Analgesics, Opioid - adverse effects | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Erythema - diagnosis | Dacarbazine - analogs & derivatives | Oxycodone - adverse effects | Acetaminophen - therapeutic use | Proton Pump Inhibitors - adverse effects | Omeprazole - therapeutic use | Immunologic Factors - administration & dosage | Omeprazole - adverse effects | Proton Pump Inhibitors - therapeutic use | Piperidines - therapeutic use | Quinazolines - therapeutic use | Piperidines - adverse effects | Quinazolines - adverse effects | Drug Combinations | Immunologic Factors - therapeutic use | Methylprednisolone - administration & dosage | Medicine, Experimental | Toxic epidermal necrolysis | Medical research | Research
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 02/2017, Volume 76, Issue 2, pp. 318 - 328
... to specialists and investigations results in high healthcare use, for up to 10 years prior to diagnosis, compared with persons who do not have fibromyalgia. 4 Although pain... 
CLINICAL-PRACTICE GUIDELINES | RANDOMIZED CONTROLLED-TRIALS | COGNITIVE-BEHAVIORAL THERAPIES | MIND-BODY THERAPIES | COMPARATIVE EFFICACY | CHRONIC PAIN | AEROBIC EXERCISE | RHEUMATOLOGY | NONPHARMACOLOGICAL INTERVENTIONS | STRESS REDUCTION | PHARMACOLOGICAL-TREATMENTS | Fibromyalgia - therapy | Capsaicin - therapeutic use | Humans | Cognitive Behavioral Therapy | Acupuncture Therapy | Exercise Therapy | Activities of Daily Living | Human Growth Hormone - therapeutic use | Societies, Medical | Fatigue - therapy | Amitriptyline - analogs & derivatives | Mind-Body Therapies | Sensory System Agents - therapeutic use | Manipulation, Chiropractic | Monoamine Oxidase Inhibitors - therapeutic use | Europe | Serotonin Uptake Inhibitors - therapeutic use | Anticonvulsants - therapeutic use | Biofeedback, Psychology | Treatment Outcome | Evidence-Based Medicine | Mindfulness | Hydrotherapy | Sleep | Antidepressive Agents, Tricyclic - therapeutic use | S-Adenosylmethionine - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Pain - physiopathology | Fatigue - physiopathology | Amitriptyline - therapeutic use | Hypnosis | Serotonin and Noradrenaline Reuptake Inhibitors - therapeutic use | Massage | Fibromyalgia - physiopathology | Sodium Oxybate - therapeutic use | Practice Guidelines as Topic
Journal Article